Application of Circulating Tumor Cell (CTC) PD-L1 Detection in the Evaluation of Therapeutic Efficacy in Advanced NSCLC: A Retrospective Study

被引：0
|
作者：
Deng, Y. [1 ]
Huang, Y. [2 ]
Cai, S. [1 ]
Yu, Z. [1 ]
Guo, X. [1 ]
机构：
[1] Shenzhen Canc Hosp, Shenzhen, Peoples R China
[2] Cell Shenzhen, Shenzhen, Peoples R China
来源：
JOURNAL OF THORACIC ONCOLOGY | 2024年 / 19卷 / 10期
关键词：
NSCLC; circulating tumor cell; immunotherapy;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
EP.11A.11
引用
收藏
页码：S600 / S600
页数：1
相关论文
共 50 条
  • [1] Circulating Tumor Cell PD-L1 Expression as Biomarker for Therapeutic Efficacy of Immune Checkpoint Inhibition in NSCLC
    Kloten, Vera
    Lampignano, Rita
    Krahn, Thomas
    Schlange, Thomas
    CELLS, 2019, 8 (08)
  • [2] Longitudinal evaluation of PD-L1 expression on circulating tumor cells in advanced NSCLC patients treated with nivolumab
    Sato, Koichi
    Koh, Yasuhiro
    Ikeda, Mio
    Akamatsu, Hiroaki
    Ueda, Hiroki
    Yamamoto, Nobuyuki
    CANCER SCIENCE, 2021, 112 : 533 - 533
  • [3] Evaluation of PD-L1/PD-1 on circulating tumor cells (CTCs) and on primary tumor in advanced non-small cell lung cancer (NSCLC)
    Kallergi, Galaktea
    Vetsika, Eleni Kyriaki
    Aggouraki, Despoina
    Lagoudaki, Eleni
    Koutsopoulos, Anastasios
    Koinis, Filippos
    Katsarlinos, Panagiotis
    Trypaki, Maria
    Stournaras, Christos
    Georgoulias, Vassilis
    Kotsakis, Athanasios
    CANCER RESEARCH, 2017, 77
  • [4] Circulating tumor cells PD-L1 expression detection and correlation of therapeutic efficacy of immune checkpoint inhibition in advanced non-small-cell lung cancer
    Zhou, Qing
    Liu, Xiangning
    Li, Ji
    Tong, Bing
    Xu, Yan
    Chen, Minjiang
    Liu, Xiaoyan
    Gao, Xiaoxing
    Shi, Yuequan
    Zhao, Jing
    Zhong, Wei
    Wang, Mengzhao
    THORACIC CANCER, 2023, 14 (05) : 470 - 478
  • [5] Circulating miRNAs and PD-L1 Tumor Expression Are Associated with Survival in Advanced NSCLC Patients Treated with Immunotherapy: a Prospective Study
    Boeri, Mattia
    Milione, Massimo
    Proto, Claudia
    Signorelli, Diego
    Lo Russo, Giuseppe
    Galeone, Carlotta
    Verri, Carla
    Mensah, Mavis
    Centonze, Giovanni
    Martinetti, Antonia
    Sottotetti, Elisa
    Pastorino, Ugo
    Garassino, Marina Chiara
    Sozzi, Gabriella
    CLINICAL CANCER RESEARCH, 2019, 25 (07) : 2166 - 2173
  • [6] Clinical significance of inter-assay discrepancy in PD-L1 evaluation for the efficacy of pembrolizumab in advanced NSCLC with high PD-L1 expression
    Miyakoshi, Jun
    Yoshida, Tatsuya
    Kashima, Jumpei
    Shirasawa, Masayuki
    Torasawa, Masahiro
    Matsumoto, Yuji
    Masuda, Ken
    Shinno, Yuki
    Okuma, Yusuke
    Goto, Yasushi
    Horinouchi, Hidehito
    Shiraishi, Kouya
    Kohno, Takashi
    Yamamoto, Noboru
    Yatabe, Yasushi
    Suzuki, Takuji
    Ohe, Yuichiro
    LUNG CANCER, 2024, 191
  • [7] Determination of PD-L1 Expression in Circulating Tumor Cells of NSCLC Patients and Correlation with Response to PD-1/PD-L1 Inhibitors
    Janning, Melanie
    Kobus, Franca
    Babayan, Anna
    Wikman, Harriet
    Velthaus, Janna-Lisa
    Bergmann, Sonja
    Schatz, Stefanie
    Falk, Markus
    Berger, Lars-Arne
    Boettcher, Lisa-Marie
    Paesler, Sarina
    Gorges, Tobias M.
    O'Flaherty, Linda
    Hille, Claudia
    Joosse, Simon A.
    Simon, Ronald
    Tiemann, Markus
    Bokemeyer, Carsten
    Reck, Martin
    Riethdorf, Sabine
    Pantel, Klaus
    Loges, Sonja
    CANCERS, 2019, 11 (06):
  • [8] PD-L1 expression analysis of circulating tumor cells in advanced renal cell carcinoma
    Nagata, Masayoshi
    Kanayama, Mayuko
    Nagaya, Naoya
    Horie, Shigeo
    CANCER SCIENCE, 2018, 109 : 970 - 970
  • [9] Evaluation of PD-L1/PD-1 on circulating tumor cells in patients with advanced non-small cell lung cancer
    Kallergi, Galatea
    Vetsika, Eleni-Kyriaki
    Aggouraki, Despoina
    Lagoudaki, Eleni
    Koutsopoulos, Anastasios
    Koinis, Filippos
    Katsarlinos, Panagiotis
    Trypaki, Maria
    Messaritakis, Ippokratis
    Stournaras, Christos
    Georgoulias, Vassilis
    Kotsakis, Athanasios
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2018, 10
  • [10] Correlation of Tumor Metabolism with Circulating and Tissue Levels of PD-L1 in Patients with NSCLC
    Lopci, E.
    Castello, A.
    Rossi, S.
    Mazziotti, E.
    Toschi, L.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 46 (SUPPL 1) : S576 - S576
12345